LRRK2 and Parkinson disease: Interestingly, they reported caffeine and its metabolites to be decreased among PD patients, with higher levels in those carrying a LRRK2 mutation, suggesting a protective effect of caffeine and an environmental interaction in genetic mutation carriers.